| AZN | 8.31% | 14,346.0 | +2.41% | 85,613 | |
| BARC | 5.51% | 479.80 | +0.51% | 1,660,839 | |
| LLOY | 5.13% | 101.00 | -0.35% | 7,488,262 | |
| RKT | 5.07% | 6,184.0 | -0.10% | 120,099 | |
| GSK | 5.06% | 1,880.50 | +1.21% | 390,778 | |
| AHT | 4.31% | 5,270.0 | -2.12% | 114,694 | |
| REL | 4.07% | 3,091.00 | -1.06% | 188,654 | |
| III | 3.77% | 3,040.73 | -0.73% | 175,040 | |
| STAN | 3.71% | 1,850.00 | +0.98% | 299,762 | |
| NG | 3.55% | 1,167.00 | +1.17% | 437,986 |
Amundi Index Solutions - Amundi MSCI UK IMI SRI is an exchange traded fund launched by Amundi Luxembourg S.A. It is managed by Amundi Asset Management. The fund invests in the public equity markets of the United Kingdom. It uses derivatives such as swaps to invest in the stocks of companies operating across diversified sectors. The fund invests in the stocks of large-cap companies. It seeks to replicate the performance of the FTSE 100 Index, by employing synthetic replication methodology. Formerly known as Amundi Index Solutions - Amundi ETF FTSE 100. Amundi Index Solutions - Amundi MSCI UK IMI SRI was formed on June 29, 2016 and is domiciled in Luxembourg.